How is plecanatide used in the treatment of constipation and what was the FDA approval based on?

Updated: Mar 30, 2020
  • Author: Marc D Basson, MD, PhD, MBA, FACS; Chief Editor: BS Anand, MD  more...
  • Print

The FDA approved plecanatide, a GC-C agonist, in January 2017 to treat chronic idiopathic constipation in adults. [8] Approval was based on two randomized controlled trials that demonstrated significant improvements in stool frequency, stool consistency, and time of bowel movement compared with placebo. [8, 9]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!